Control of hepatitis B virus infection by vaccination: The Taiwan experience

Chinese Medical Journal (Taipei)

Volumn 61, Issue 9, 1998, Pages 501-506

  Lee, Shou Dong ^a,b   Lo, Kwang Juei ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Hepatitis B vaccine; Hepatitis B virus; Liver diseases; Mass vaccination; Neonates

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; MEASLES VACCINE; RECOMBINANT VACCINE;

CANCER INCIDENCE; CHILD; CHILDHOOD CANCER; CHRONIC HEPATITIS; COST BENEFIT ANALYSIS; FEVER; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NEWBORN; REVIEW; TAIWAN; VACCINATION; VIRUS CARRIER; VIRUS TRANSMISSION;

HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT, NEWBORN; TAIWAN; VACCINATION;

EID: 0031798472     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Beasley RP, Hwang LY. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 1984,4:113-21.
2. Blumberg BS, Alter HJ, Visnich S. A "new" antigen in leukemia sera. J Am Med Assoc 1965;191:541-6.
3. Tong MJ, Sun SC, Schaeffer BT, Chang NK, Lo KJ, Peters RL. Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med 1971;75:687-91.
4. Sung JL. Hepatitis B virus infection and its sequelae in Taiwan. Proc Natl Sci B ROC 1981;5:385-99.
5. Tong MJ, Chien MC, Lo KJ, Tsai YT, Lee JK. Hepatitis B viral markers in patients with chronic hepatitis and with primary hepatocellular carcinoma in Taiwan. Prog Med Virol 1981;27:60-5.
6. Lo KJ, Tong MJ, Chien MC, Tsai YT, Liaw YF, Yang KC, et al. The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan. J Infect Dis 1982;146:205-10.
7. Chien MC, Tong MJ, Lo KJ, Lee JK, Milich DR, Vyas GN, Murphy BL. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan. J Natl Cancer Inst 1981;66:475-9.
8. Wu TC, Tong MJ, Hwang B, Lee SD, Hu MM. Primary hepatocellular carcinoma and hepatitis B infection during childhood. Hepatology 1987;7:46-8.
9. Beasley RP, Hwang LY, Lin CC, Chien SC. Hepatocellular carcinoma and HBV: a prospective study of 22,707 men in Taiwan. Lancet 1981;ii:1129-33.
10. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. New Engl J Med 1975;292:771-4.
11. Lo KJ, Tsai YT, Lee SD, Yeh CL, Wang JY, Chiang BN, et al. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan. Hepato-Gastroenterology 1985;32:65-8.
12. Lee SD, Lo KJ, Wu JC, Tsai YT, Wang JY, Ting LP, Tong MJ. Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology 1986;6:369-73.
13. Lee SD, Lo KJ, Tsai YT, Wu JC, Wu TC, Yang IL, Ng HT. Role of Caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet 1988;ii:833-4.
14. Lee SD, Lo KJ, Tsai YT, Wu JC. Maternal hepatitis B virus DNA in mother-infant transmission. Lancet 1989;i:719.
15. Tsai YT, Lo KJ, Lee SD, Wang JY, Wu TC. Immunoprophylaxis against hepatitis B virus infection: a controlled trial in infants born to HBeAg-negative HBsAg carrier mothers in Taiwan. Chin J Gastroenterol 1984;1:181-5.
16. Lee SD, Lo KJ, Tsai YT, Wang JY, Lai KH, Yeh CL. Hepatitis B virus infection in hospital personnel in Taiwan: is immunoprophylaxis necessary? Chin Med J (Taipei) 1985;36:361-5.
17. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma - epidemiological consideration. Hepatology 1982;2:21S-26S.
18. Tsai YT, Lee JK, Jean JS, Lee SD, Chien MC, Chen GH, et al. Familial clustering of hepatitis B virus infection and primary hepatocellular carcinoma. Chin Med J (Taipei) 1979;26:12-20.
19. Lee SD. Hepatitis B vaccine (Editorial). Chin Med J (Taipei) 1984;33:229-30.
20. Chen DS, Hsu NHM, Sung JL, Hsu TC, Hsu ST, Kuo YT, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigencarrier mothers. J Am Med Assoc 1987;257:2597-603.
21. Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, Williams DC, et al. Hepatitis B vaccine. Demonstration of efficacy in controlled clinical trials in high-risk population in the United States. New Engl J Med 1980;303:833-41.
22. Maupas P, Chiron JP, Barin F, Coursaget P, Goudeau A, Perrin J, et al. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet 1981;i:289-92.
23. Lo KJ, Tsai YT, Lee SD, Wu TC, Wang JY, Chen GH, et al. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis 1985;152:817-22.
24. Tsai YT, Lo KJ, Lee SD, Wang JY, Wu JC, Chan CY, Wu TC. A comparison of immunogenicity of reduced doses of hepatitis B vaccine in infants born to noncarrier mothers in Taiwan. Chin J Gastroenterol 1987;4:56-62.
25. Hsu HM, Chen DS, Chuang CH, Lu JC, Jwo DM, Lee CC, et al. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3,464 infants of hepatitis B surface antigen-carrier mothers. J Am Med Assoc 1988;260:2231-5.
26. Lo KJ, Lee SD, Tsai YT, Wu TC, Chan CY, Chen GH, Yeh CL. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers. Hepatology 1988;8:1647-50.
27. Lo KJ, Lee SD, Tsai YT, Wu TC, Yu MY, Wang YJ, Chan CY. Hepatitis B vaccine trial in neonates. J Gastroenterol Hepatol 1993;8:S99-S102.
28. Chan CY, Lee SD, Tsai YT, Yue MI, Lo KJ. Long-term follow-up of hepatitis B vaccination in infants born to noncarrier mothers in Taiwan. Chin Med J (Taipei) 1992;50:83-8.
29. Lee SD, Lo KJ, Tsai YT, Chan CY, Wu TC. The second booster for the previously hepatitis B vaccine immunized high risk children. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1991:776-8.
30. Chan CY, Lee SD, Tsai YT, Lo KJ. Booster response to recombinant yeast-derived hepatitis B vaccine in vaccinees whose anti-HBcA responses were initially elicited by a plasma-derived vaccine. Vaccine 1991;9:765-7.
31. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. J Am Med Assoc 1996;276:906-8.
32. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. New Engl J Med 1997;336:1855-9.